Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

PROFARMA ON NM (PFRM3)

B3
Currency in BRL
Disclaimer
6.01
-0.26(-4.15%)
Delayed Data
PFRM3 Scorecard
Earnings results expected in 13 days
Fair Value
Unlock Value
Day's Range
5.936.26
52 wk Range
2.876.33
Bid/Ask
6.01 / 6.03
Prev. Close
6.27
Open
6.25
Day's Range
5.93-6.26
52 wk Range
2.87-6.33
Volume
203,400
Average Vol. (3m)
249,860
1-Year Change
117.65%
Shares Outstanding
122,610,773
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More

People Also Watch

5.47
POMO3
-1.08%
7.65
VINO11
-0.52%
2.23
LPSB3
-0.89%
4.99
FHER3
-0.20%
4.52
PINE4
+0.22%
How do you feel today about PFRM3?
Vote to see community's results!
or

PROFARMA ON NM Company Profile

Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical products in Brazil. The company operates through two segments, Distribution and Retail segments. It provides medicines, human drugs, personal hygiene, veterinary, perfumery, and cosmetic and beauty products. The company operates retail stores under the Drogasmil, Farmalife, Tamoio, and Rede Rosário brands. Profarma Distribuidora de Produtos Farmacêuticos S.A. was incorporated in 1961 and is headquartered in Rio De Janeiro, Brazil.

Employees
7077
Market
Brazil
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.